Skip to main content

Bipolar Disorders

The 6-item Rapid Mood Screener outperformed the Mood Disorder Questionnaire in differentiating bipolar I disorder from major depressive disorder, according to a study published online in Current Medical Research and Opinion.
A new study finds that decreased activation of the LEF1 gene in patients with bipolar disorder could be a useful biomarker for lithium nonresponsiveness, streamlining treatment.
After receiving a diagnosis, many patients are brimming with questions. Help your patients find accurate and trustworthy information with this handout.
The US Food and Drug Administration (FDA) has accepted Alkermes’ resubmission of the New Drug Application for ALKS 3831, a combination of olanzapine and samidorphan, the company announced.
Explore some of the resources on the recently launched NP Psych Navigator platform, which connects nurse practitioners with tools to help them identify mental illness and care for affected patients and their families.
Back to Top